These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8694513)

  • 1. Proton nuclear magnetic resonance spectroscopy of plasma lipoprotein: technical problems and potential interest in cancer disease.
    de Certaines JD; Nadal L; Leray G; Serrai H; Lewa CJ
    Anticancer Res; 1996; 16(3B):1451-60. PubMed ID: 8694513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
    Engan T
    Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial neural network analysis of 1H nuclear magnetic resonance spectroscopic data from human plasma.
    Ala-Korpela M; Hiltunen Y; Bell JD
    Anticancer Res; 1996; 16(3B):1473-7. PubMed ID: 8694515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
    Suna T; Salminen A; Soininen P; Laatikainen R; Ingman P; Mäkelä S; Savolainen MJ; Hannuksela ML; Jauhiainen M; Taskinen MR; Kaski K; Ala-Korpela M
    NMR Biomed; 2007 Nov; 20(7):658-72. PubMed ID: 17212341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.
    Bathen TF; Engan T; Krane J; Axelson D
    Anticancer Res; 2000; 20(4):2393-408. PubMed ID: 10953302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NMR blood test for cancer: current status.
    Fossel ET
    Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of NMR spectra with chemometrics.
    Winning H; Larsen FH; Bro R; Engelsen SB
    J Magn Reson; 2008 Jan; 190(1):26-32. PubMed ID: 18029207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients.
    Le Moyec L; Valensi P; Charniot JC; Hantz E; Albertini JP
    NMR Biomed; 2005 Nov; 18(7):421-9. PubMed ID: 16075416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?
    Leray G; de Certaines JD
    Anticancer Res; 1994; 14(5A):1839-51. PubMed ID: 7847817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-domain quantification of multiple-quantum-filtered (23)Na signal using continuous wavelet transform analysis.
    Serrai H; Borthakur A; Senhadji L; Reddy R; Bansal N
    J Magn Reson; 2000 Feb; 142(2):341-7. PubMed ID: 10648152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples.
    Smith LM; Maher AD; Cloarec O; Rantalainen M; Tang H; Elliott P; Stamler J; Lindon JC; Holmes E; Nicholson JK
    Anal Chem; 2007 Aug; 79(15):5682-9. PubMed ID: 17585837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral fitting of NMR spectra using an alternating optimization method with a priori knowledge.
    Bi Z; Bruner AP; Li J; Scott KN; Liu ZS; Stopka CB; Kim HW; Wilson DC
    J Magn Reson; 1999 Sep; 140(1):108-19. PubMed ID: 10479553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of signal processing methods for the quantification of a multi-exponential signal: the glycogen 13C-1 NMR signal.
    Overloop K; Van Hecke P; Vanstapel F; Chen H; Van Huffel S; Knijn A; van Ormondt D
    NMR Biomed; 1996 Oct; 9(7):315-21. PubMed ID: 9134542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR signal enhancement via a new time-frequency transform.
    Ahmed OA; Fahmy MM
    IEEE Trans Med Imaging; 2001 Oct; 20(10):1018-25. PubMed ID: 11686437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of the relative plasma concentrations of methyl and methylene groups in cancer: a study using proton NMR spectroscopy].
    Vion-Dury J; Sciaky M; Confort-Gouny S; Kriat M; Favre R; Grisoli F; Harlé JR; Fontanarava E; Mongin M; Carcassonne Y
    C R Acad Sci III; 1989; 309(10):415-8. PubMed ID: 2514967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism.
    Moolenaar SH; Engelke UF; Wevers RA
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):16-24. PubMed ID: 12542907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction kinetics studied using diffusion-ordered spectroscopy and multiway chemometrics.
    Khajeh M; Botana A; Bernstein MA; Nilsson M; Morris GA
    Anal Chem; 2010 Mar; 82(5):2102-8. PubMed ID: 20131871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.
    Jeyarajah EJ; Cromwell WC; Otvos JD
    Clin Lab Med; 2006 Dec; 26(4):847-70. PubMed ID: 17110242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.